Synergy has a new indication for its gastrointestinal med Trulance, and to celebrate, it’s bringing its contract sales force on full time. Two hundred reps from Publicis Touchpoint will join the New ...
NEW YORK--(BUSINESS WIRE)-- Synergy Pharmaceuticals Inc. (NAS: SGYP) today announced presentations on plecanatide and SP-333, its proprietary guanylate cyclase-C (GC-C) agonists in development for ...